Retinal vascular tortuosity in schizophrenia and bipolar disorder.


Journal

Schizophrenia research
ISSN: 1573-2509
Titre abrégé: Schizophr Res
Pays: Netherlands
ID NLM: 8804207

Informations de publication

Date de publication:
10 2019
Historique:
received: 02 01 2019
revised: 23 04 2019
accepted: 18 08 2019
pubmed: 31 8 2019
medline: 6 10 2020
entrez: 31 8 2019
Statut: ppublish

Résumé

The micro-vasculature of retina and brain share common morphological, physiological, and pathological properties. Retina being easily accessible, retinal vascular examination provides an indirect assessment of cerebral vasculature. Considering the high prevalence of vascular morbidity in SCZ and BD a few studies have examined retinal vascular caliber and have reported increased retinal venular caliber in schizophrenia (SCZ). Retinal vascular tortuosity could serve as a better structural measure than caliber as it is static and less susceptible to pulse period variations. However, to date, no study has examined retinal vascular tortuosity in SCZ and bipolar disorder (BD). Hence, we examined retinal vascular tortuosity in comparison with healthy volunteers (HV). We included 255 subjects (78 HV, 79 SCZ, and 86 BD) in the age range of 18 to 50 years. Trained personnel acquired images using a non-mydriatic fundus camera. To measure the average retinal arteriolar tortuosity index (RATI) and retinal venular tortuosity index (RVTI), we used a previously validated, semi-automatic algorithm. The results showed significant differences across the three groups in RATI but not in RVTI; both BD and SCZ had significantly increased RATI compared to HV. There was also a significant difference between SCZ and BD, with BD having higher RATI. If shown to be of predictive utility in future longitudinal studies, it has the potential to identify patients at risk of development of adverse vascular events. As retinal vascular imaging is non-invasive and inexpensive, it could serve as a proxy marker and window to cerebral vasculature.

Identifiants

pubmed: 31466896
pii: S0920-9964(19)30375-5
doi: 10.1016/j.schres.2019.08.020
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

26-32

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Abhishek Appaji (A)

Department of Medical Electronics, B.M.S. College of Engineering, Bangalore, India; University Eye Clinic Maastricht, Maastricht University, Maastricht, the Netherlands.

Bhargavi Nagendra (B)

Dept. of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, India.

Dona Maria Chako (DM)

Dept. of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, India.

Ananth Padmanabha (A)

Department of Medical Electronics, B.M.S. College of Engineering, Bangalore, India.

Arpitha Jacob (A)

Dept. of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, India.

Chaitra V Hiremath (CV)

Dept. of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, India.

Shivarama Varambally (S)

Dept. of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, India.

Muralidharan Kesavan (M)

Dept. of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, India.

Ganesan Venkatasubramanian (G)

Dept. of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, India.

Shyam Vasudeva Rao (SV)

Department of Medical Electronics, B.M.S. College of Engineering, Bangalore, India; University Eye Clinic Maastricht, Maastricht University, Maastricht, the Netherlands.

Carroll A B Webers (CAB)

University Eye Clinic Maastricht, Maastricht University, Maastricht, the Netherlands.

Tos T J M Berendschot (TTJM)

University Eye Clinic Maastricht, Maastricht University, Maastricht, the Netherlands.

Naren P Rao (NP)

Dept. of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, India. Electronic address: docnaren@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH